Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery - PubMed
Clinical Trial
Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery
H Quiding et al. Eur J Clin Pharmacol. 1993.
Abstract
A double blind randomised cross over investigation was carried out in 25 male patients undergoing two oral surgical extractions, one for each lower wisdom tooth. The two extractions were performed about 6 weeks apart and were carried out under local anaesthesia. One hour after each extraction the patients randomly received 90 or 45 mg codeine. During the following 5 h the patients rated the intensity of their pain on a visual analogue scale. Blood was simultaneously sampled and assayed for codeine and its metabolite morphine. Mean pain intensity difference was just significantly higher after 90 mg codeine compared to 45 mg. The mean plasma concentrations of codeine and morphine were significantly higher after the 90 mg dose. However, for the two dose levels of codeine there was no obvious relationship between the difference in analgesic effect and the difference in the plasma concentration of codeine or morphine. The plasma concentrations of morphine were 2-3% of those of codeine and the levels were relatively low. Local formation of morphine from codeine within the human brain should therefore be investigated. Four patients were unable to demethylate codeine to a detectable plasma concentration of morphine after 90 mg codeine. In those patients the analgesic effect during the first hours was better after 90 mg codeine than after 45 mg. This suggests some analgesic effect of codeine itself.
Similar articles
-
Quiding H, Anderson P, Bondesson U, Boréus LO, Hynning PA. Quiding H, et al. Eur J Clin Pharmacol. 1986;30(6):673-7. doi: 10.1007/BF00608214. Eur J Clin Pharmacol. 1986. PMID: 3770062
-
Poulsen L, Riishede L, Brøsen K, Clemensen S, Sindrup SH. Poulsen L, et al. Eur J Clin Pharmacol. 1998 Aug;54(6):451-4. doi: 10.1007/s002280050491. Eur J Clin Pharmacol. 1998. PMID: 9776433
-
Petersen JK, Hansson F, Strid S. Petersen JK, et al. J Oral Maxillofac Surg. 1993 Jun;51(6):637-40. doi: 10.1016/s0278-2391(10)80262-9. J Oral Maxillofac Surg. 1993. PMID: 8492200 Clinical Trial.
-
Hellman M, Ahlström U, Andersson L, Strid S. Hellman M, et al. Eur J Clin Pharmacol. 1992;43(4):347-50. doi: 10.1007/BF02220607. Eur J Clin Pharmacol. 1992. PMID: 1451712 Clinical Trial.
-
Sagne S, Henrikson PA, Kahnberg KE, Thilander H, Bertilson SO. Sagne S, et al. J Int Med Res. 1987 Mar-Apr;15(2):83-8. doi: 10.1177/030006058701500204. J Int Med Res. 1987. PMID: 3556263 Clinical Trial.
Cited by
-
Lötsch J, Skarke C, Liefhold J, Geisslinger G. Lötsch J, et al. Clin Pharmacokinet. 2004;43(14):983-1013. doi: 10.2165/00003088-200443140-00003. Clin Pharmacokinet. 2004. PMID: 15530129 Review.
-
Role of active metabolites in the use of opioids.
Coller JK, Christrup LL, Somogyi AA. Coller JK, et al. Eur J Clin Pharmacol. 2009 Feb;65(2):121-39. doi: 10.1007/s00228-008-0570-y. Epub 2008 Oct 29. Eur J Clin Pharmacol. 2009. PMID: 18958460 Review.
-
Codeine and clinical impairment in samples in which morphine is not detected.
Bachs L, Skurtveit S, Mørland J. Bachs L, et al. Eur J Clin Pharmacol. 2003 Apr;58(12):785-9. doi: 10.1007/s00228-003-0561-y. Epub 2003 Mar 1. Eur J Clin Pharmacol. 2003. PMID: 12698303
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources